RA
SILK

RiverPark Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

RiverPark Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,271
Closed -$34K – 112
2023
Q3 		$34K Buy
+2,271
New +$47.3K 0.03% 78

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RiverPark Advisors's SILK Position: Q4 2023 in Review

RiverPark Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 2,271 shares — an estimated $34K sold.

RiverPark Advisors first reported a position in SILK in Q3 2023 and held it in 1 quarter. The position peaked at $34K in Q3 2023. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • RiverPark Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • RiverPark Advisors sold 2,271 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $34K.
  • RiverPark Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • RiverPark Advisors's Silk Road Medical, Inc. Common Stock position peaked at $34K in Q3 2023.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on RiverPark Advisors's 13F filing for Q4 2023, filed 11 Jan 2024.